Explore

Trendline Trendline
Guided Therapeutics Inc Reports No Revenue and Increased Net Loss in Q1 2026

Guided Therapeutics Inc Reports No Revenue and Increased Net Loss in Q1 2026

Guided Therapeutics Inc Reports No Revenue and Increased Net Loss in Q1 2026
Trendline Trendline
Citius Oncology Reports Strong Financial Growth and Strategic Developments in Q2 2026

Citius Oncology Reports Strong Financial Growth and Strategic Developments in Q2 2026

Citius Oncology Reports Strong Financial Growth and Strategic Developments in Q2 2026
Trendline Trendline
Guided Therapeutics Reports Q1 2026 Financial Results with No Revenue

Guided Therapeutics Reports Q1 2026 Financial Results with No Revenue

Guided Therapeutics Reports Q1 2026 Financial Results with No Revenue
Trendline Trendline
Guided Therapeutics Reports Q1 2026 Financial Results Amid Regulatory Progress

Guided Therapeutics Reports Q1 2026 Financial Results Amid Regulatory Progress

Guided Therapeutics Reports Q1 2026 Financial Results Amid Regulatory Progress
Trendline Trendline
Fosun Pharma and AriBio Sign Agreement for Alzheimer's Drug Development

Fosun Pharma and AriBio Sign Agreement for Alzheimer's Drug Development

Fosun Pharma and AriBio Sign Agreement for Alzheimer's Drug Development
Trendline Trendline
Legend Biotech Reports Strong Q1 2026 Growth Driven by CARVYKTI Expansion

Legend Biotech Reports Strong Q1 2026 Growth Driven by CARVYKTI Expansion

Legend Biotech Reports Strong Q1 2026 Growth Driven by CARVYKTI Expansion
Trendline Trendline
Atossa Therapeutics Hosts Event on (Z)-Endoxifen for ER-Positive Breast Cancer

Atossa Therapeutics Hosts Event on (Z)-Endoxifen for ER-Positive Breast Cancer

Atossa Therapeutics Hosts Event on (Z)-Endoxifen for ER-Positive Breast Cancer
Trendline Trendline
FDA Approves BeOne's New Therapy for Mantle Cell Lymphoma

FDA Approves BeOne's New Therapy for Mantle Cell Lymphoma

FDA Approves BeOne's New Therapy for Mantle Cell Lymphoma
Trendline Trendline
Arna Pharma and Slate Run Pharmaceuticals Launch Joint Venture and First Product

Arna Pharma and Slate Run Pharmaceuticals Launch Joint Venture and First Product

Arna Pharma and Slate Run Pharmaceuticals Launch Joint Venture and First Product
Trendline Trendline
Atisama Therapeutics Advances RB042 in Phase 1 Trial and Appoints New Board Chair

Atisama Therapeutics Advances RB042 in Phase 1 Trial and Appoints New Board Chair

Atisama Therapeutics Advances RB042 in Phase 1 Trial and Appoints New Board Chair
Trendline Trendline
Alpha Cognition Reports Strong Q1 2026 Financial Results and Operational Progress

Alpha Cognition Reports Strong Q1 2026 Financial Results and Operational Progress

Alpha Cognition Reports Strong Q1 2026 Financial Results and Operational Progress
Trendline Trendline
Veracyte Reports Strong Q1 Earnings, Boosting Stock by 23%

Veracyte Reports Strong Q1 Earnings, Boosting Stock by 23%

Veracyte Reports Strong Q1 Earnings, Boosting Stock by 23%